Unknown

Dataset Information

0

Getting Under the Skin: Targeting Cutaneous Autoimmune Disease.


ABSTRACT: Autoimmune diseases of the skin occur when the immune system attacks normal skin. The immune system can be broadly divided into an effector arm responsible for fighting infections and cancer and a regulatory arm that reduces autoreactivity and maintains immune homeostasis. Cutaneous autoimmunity develops when the equilibrium between the effector arm and regulatory arm of the immune system is disrupted. Recent insights into the inflammatory pathways that are overactive in some cutaneous autoimmune diseases have led to therapies targeting the effector arm of the immune system with greater treatment efficacy than previously used broad immunosuppressants. The current paradigm of inhibiting excessive immune activation for treating cutaneous autoimmunity will be discussed including cytokine blockade, cellular depletion, intracellular signaling blockade and costimulatory blockade. Despite the success of this approach many cutaneous autoimmune diseases lack a clearly delineated pathway to target and therefore new strategies are needed. An emerging therapeutic strategy targeting the regulatory arm of the immune system to induce tolerance and disease remission provides new hope for treating cutaneous autoimmunity. Such an approach includes cellular therapy with regulatory T cells and chimeric autoantibody receptor T cells, cytokine therapy with low-dose interleukin-2, immune checkpoint stimulation, tolerogenic vaccines and microbiome biotherapy. This mini-review will discuss the current and emerging therapeutic strategies for cutaneous autoimmune diseases and provide an organizational framework for understanding distinct mechanisms of action.

SUBMITTER: Vesely MD 

PROVIDER: S-EPMC7087062 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Getting Under the Skin: Targeting Cutaneous Autoimmune Disease.

Vesely Matthew D MD  

The Yale journal of biology and medicine 20200327 1


Autoimmune diseases of the skin occur when the immune system attacks normal skin. The immune system can be broadly divided into an effector arm responsible for fighting infections and cancer and a regulatory arm that reduces autoreactivity and maintains immune homeostasis. Cutaneous autoimmunity develops when the equilibrium between the effector arm and regulatory arm of the immune system is disrupted. Recent insights into the inflammatory pathways that are overactive in some cutaneous autoimmun  ...[more]

Similar Datasets

| S-EPMC9952967 | biostudies-literature
| S-EPMC6794457 | biostudies-literature
| S-EPMC8907585 | biostudies-literature
| S-EPMC4154900 | biostudies-literature
| S-EPMC152302 | biostudies-literature
| S-EPMC7762338 | biostudies-literature
| S-EPMC4019044 | biostudies-literature
| S-EPMC8712646 | biostudies-literature
2014-12-18 | E-GEOD-64276 | biostudies-arrayexpress
| S-EPMC7531612 | biostudies-literature